Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies

被引：0
|
作者：
Pedro C. Barata
Dhrmesh Gopalakrishnan
Vadim S. Koshkin
Prateek Mendiratta
Matt Karafa
Kimberly Allman
Allison Martin
Jennifer Beach
Pam Profusek
Allison Tyler
Laura Wood
Moshe Ornstein
Timothy Gilligan
Brian I. Rini
Jorge A. Garcia
Petros Grivas
机构：
[1] Taussig Cancer Institute Cleveland Clinic,Department of Hematology & Medical Oncology
[2] Cleveland Clinic,Department of Hospital Medicine
[3] Cleveland Clinic,Quantitative Health Sciences
[4] University of Washington and Fred Hutchinson Cancer Research Center,Department of Medicine, Division of Oncology
[5] Seattle Cancer Care Alliance,undefined
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 361
页数：8
相关论文
共 50 条
  • [1] Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies
    Barata, Pedro C.
    Gopalakrishnan, Dhrmesh
    Koshkin, Vadim S.
    Mendiratta, Prateek
    Karafa, Matt
    Allman, Kimberly
    Martin, Allison
    Beach, Jennifer
    Profusek, Pam
    Tyler, Allison
    Wood, Laura
    Ornstein, Moshe
    Gilligan, Timothy
    Rini, Brian I.
    Garcia, Jorge A.
    Grivas, Petros
    TARGETED ONCOLOGY, 2018, 13 (03) : 353 - 361
  • [2] Atezolizumab (atezo) and subsequent therapies in patients (Pts) with metastatic urothelial carcinoma (mUC) outside clinical trials.
    Barata, Pedro C.
    Koshkin, Vadim S.
    Mendiratta, Prateek
    Gopalakrishnan, Dharmesh
    Karafa, Matt
    Allman, Kimberly D.
    Martin, Allison
    Beach, Jennifer
    Profusek, Pam
    Tyler, Allison Janine
    Wood, Laura S.
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [3] Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma
    Stroh, M.
    Winter, H.
    Marchand, M.
    Claret, L.
    Eppler, S.
    Ruppel, J.
    Abidoye, O.
    Teng, S. L.
    Lin, W. T.
    Dayog, S.
    Bruno, R.
    Jin, J.
    Girish, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 305 - 312
  • [4] A drug safety evaluation of atezolizumab in locally advanced or metastatic urothelial carcinoma
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Bamias, Aristotelis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 955 - 960
  • [5] Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC)
    Bedke, Jens
    Merseburger, Axel Stuart
    Loriot, Yohann
    Castellano, Daniel
    Choy, Ernest
    Duran, Ignacio
    Rosenberg, Jonathan E.
    Petrylak, Daniel Peter
    Dreicer, Robert
    Perez-Gracia, Jose Luis
    Hoffman-Censits, Jean H.
    Van Der Heijden, Michiel Simon
    Degaonkar, Viraj
    Thiebach, Lars
    de Ducla, Sabine
    Fear, Simon
    Powles, Thomas
    Sternberg, Cora N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC)
    Bedke, J.
    Merseburger, A. S.
    Loriot, Y.
    Castellano, D.
    Choy, E.
    Duran, I.
    Rosenberg, J.
    Petrylak, D. P.
    Dreicer, R.
    Perez-Gracia, J. L.
    Hoffman-Censits, J. H.
    Van der Heijden, M. S.
    Degaonkar, V.
    Thiebach, L.
    de Ducla, S.
    Fear, S.
    Powles, T.
    Sternberg, C. N.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 255 - 256
  • [7] Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Artac, Mehmet
    Ozhan, Nail
    Akar, Emre
    Cakar, Burcu
    Kostek, Osman
    Ekenel, Meltem
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Yilmaz, Ugur
    Bilgetekin, Irem
    Yildiz, Birol
    Sendur, Mehmet Ali Nahit
    Erman, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [8] Evaluation of the safety and efficacy of daratumumab outside of clinical trials
    Kobayashi, Hiroki
    Tsushima, Takafumi
    Terao, Toshiki
    Abe, Yoshiaki
    Miura, Daisuke
    Narita, Kentaro
    Kitadate, Akihiro
    Takeuchi, Masami
    Matsue, Kosei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (06) : 665 - 672
  • [9] Evaluation of the safety and efficacy of daratumumab outside of clinical trials
    Hiroki Kobayashi
    Takafumi Tsushima
    Toshiki Terao
    Yoshiaki Abe
    Daisuke Miura
    Kentaro Narita
    Akihiro Kitadate
    Masami Takeuchi
    Kosei Matsue
    International Journal of Hematology, 2019, 109 : 665 - 672
  • [10] Efficacy and safety of atezolizumab in the treatment of urothelial carcinoma: a systematic review and meta-analysis
    Jun Xie
    Qiu-yu Mao
    Jun-hao Chen
    Hong-jin Shi
    Pei-qin Zhan
    Hai-feng Wang
    World Journal of Surgical Oncology, 23 (1)
12345